Medical societies, aging advocates share early reactions to new TAVR policies
The American College of Cardiology (ACC), Society of Thoracic Surgeons (STS) and Society for Cardiovascular Angiography and Interventions (SCAI), three of the leading cardiovascular health organizations in the United States, have shared a joint statement on new transcatheter aortic valve replacement (TAVR) policies finalized by the U.S. Centers for Medicare and Medicaid Services (CMS).
The changes, among other things, include Medicare covering TAVR in asymptomatic patients, and the fact that coverage with evidence development (CED) requirements are no longer in place when performing TAVR on symptomatic patients. Click here for a full rundown of the new TAVR coverage policies.
In their statement, the three groups wrote that they appreciate CMS’s efforts to evolve coverage policies for TAVR as time goes on.
“As TAVR expands into new patient populations, it is critical to preserve the quality framework that has contributed to its success,” the groups wrote. “The preservation of the heart team, continued collaboration across specialties, collection of real-world evidence, outcomes monitoring and continuous quality improvement are the foundation of ensuring and improving outcomes for our patients with severe aortic stenosis.”
They groups also pointed to the importance of continuing to take part in data registries, even when clinicians are not required to do so.
“Participation in national registries, externally benchmarked quality programs and rigorous outcomes reporting remain essential to preserving the high standards of care that have defined TAVR's success,” they wrote. “The societies will continue to support the STS/ACC TVT Registry and other quality initiatives that promote evidence generation, patient safety, continuous improvement and health care value across the cardiovascular community.”
The three groups previously collaborated on a letter asking CMS to consider keeping CED in place requirements for all TAVR procedures. They shared other recommendations as well.
Alliance for Aging Research pleased with TAVR changes
The Alliance for Aging Research, a U.S.-based nonprofit focused on advancing the science of aging, also shared a response to the new TAVR policies. The organization celebrated the changes, saying they are sure to improve patient access to this important treatment.
“We thank CMS Administrator Dr. Mehmet Oz for listening to patients and advocates—and for turning that listening into action,” the group said. “This decision proves that Medicare can protect quality while empowering physicians to make the best choice for their patients.”
Click here for additional details about these new policies, including statements from two leading TAVR vendors.
Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.